Sources

5 Total Sources

Pfizer Lyme Vaccine Prevents 70% of Cases in Late-Stage Study as Tick Bites Hit 2017 High

The Santa Rosa Press Democrat5h ago

Pfizer's Lyme Disease Vaccine Shows 70% Efficacy in Late-Stage Study

Lyme disease vaccine reduces risk by more than 70% in study | STAT

University of Minnesota Twin Cities5h ago

Lyme disease vaccine shows over 70% efficacy in phase 3 trial | CIDRAP

Women's Health5h ago

Pfizer Just Announced a New Lyme Disease Vaccine

Medical Xpress5h ago

Would hunters take a Lyme disease vaccine?